SCHEMBL7899682

SCHEMBL7899682

Cc1ccc(C(c2c(O)c3ccccc3oc2=O)c2c(O)c3ccccc3oc2=O)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 13/20 0.86
TOP1 P11387 1/20 0.86
CYP2C9 P11712 1/20 0.80
CRHBP P24387 1/20 0.80
CASP7 P55210 1/20 0.80
CASP6 P55212 1/20 0.80
CRHR2 Q13324 1/20 0.80
HIF1A Q16665 1/20 0.80
MGAM O43451 1/20 0.71
GAA P10253 1/20 0.71
SI P14410 1/20 0.71
MGAM2 Q2M2H8 1/20 0.71
KDM4E B2RXH2 1/20 0.70
MEN1 O00255 1/20 0.70
ALDH1A1 P00352 1/20 0.70
LMNA P02545 1/20 0.70
POLB P06746 1/20 0.70
MAPT P10636 1/20 0.70
RECQL P46063 1/20 0.70
GALK1 P51570 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4385323 0.93 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL4390609 0.89 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL14172083 0.88 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL7896856 0.88 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL12028898 0.86 NQO1 (1.00) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL12028808 0.86 NQO1 (0.86) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL7909128 0.86 NQO1 (0.86) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL14171085 0.86 NQO1 (0.72) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL12028810 0.86 NQO1 (0.86) NQO1TOP1CYP2C9CRHBPCASP7
SCHEMBL7898320 0.86 NQO1 (0.86) NQO1TOP1CYP2C9CRHBPCASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10792275-B2 Inhibiting binding of influenza-virus PB2 subunit to RNA cap SINOCLONE LTD (CN) 2020-10-06 US disclosed
US-10792275-B2 Inhibiting binding of influenza-virus PB2 subunit to RNA cap SINOCLONE LTD (CN) 2020-10-06 US disclosed
US-20190142785-A1 Compound that Inhibits Binding of Influenza-Virus PB Subunit to RNA Cap Sinoclone Ltd. (CN) 2019-05-16 US disclosed
WO-2010075280-A2 COUMARIN-BASED COMPOUNDS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2010-07-01 WO disclosed
US-20080153872-A1 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2008-06-26 US disclosed
US-20080153872-A1 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153872-A1 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity NOD1, NOD2, CASP1 NQO1 397/4885TOP1 1549/4885CYP2C9 26/4885
US-20190142785-A1 Compound that Inhibits Binding of Influenza-Virus PB Subunit to RNA Cap CNBP, NCBP1, NCBP2 NQO1 4144/4885TOP1 3590/4885CYP2C9 4148/4885
US-10792275-B2 Inhibiting binding of influenza-virus PB2 subunit to RNA cap CNBP, ZC3HAV1, RNMT NQO1 3246/4885TOP1 982/4885CYP2C9 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.